A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes
出版年份 2016 全文链接
标题
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes
作者
关键词
Pembrolizumab, Nivolumab, Ipilimumab, Diabetes mellitus, Immunomodulatory, Immune-related adverse effect
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 66, Issue 1, Pages 25-32
出版商
Springer Nature
发表日期
2016-10-19
DOI
10.1007/s00262-016-1913-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors “A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome”
- (2016) Lavinia Spain et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome
- (2016) Elizabeth Hansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
- (2016) Lars Hofmann et al. EUROPEAN JOURNAL OF CANCER
- Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient
- (2016) Yukiko Teramoto et al. JOURNAL OF DERMATOLOGY
- Genetic risk factors for type 1 diabetes
- (2016) Flemming Pociot et al. LANCET
- Nivolumab, an Anti-Programmed Cell Death-1 Antibody, Induces Fulminant Type 1 Diabetes
- (2016) Yuka Miyoshi et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy
- (2016) Masahide Okamoto et al. Journal of Diabetes Investigation
- Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma
- (2015) N. Yamazaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
- (2015) Juan Martin-Liberal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes
- (2015) R. Fujisawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes
- (2015) Caroline Gaudy et al. DIABETES CARE
- Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
- (2015) Valentina Perri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes
- (2014) Nora M. Kochupurakkal et al. PLoS One
- Ipilimumab-induced autoimmune adrenalitis
- (2013) Le Min et al. Lancet Diabetes & Endocrinology
- New-Onset Type 1 Diabetes Mellitus and Anti-Aquaporin-4 Antibody Positive Optic Neuritis Associated with Type 1 Interferon Therapy for Chronic Hepatitis C
- (2012) Tomoya Kawazoe et al. INTERNAL MEDICINE
- The role of interferon alpha in initiation of type I diabetes in the NOD mouse
- (2011) Qing Li et al. CLINICAL IMMUNOLOGY
- Genetics of the HLA Region in the Prediction of Type 1 Diabetes
- (2011) Janelle A. Noble et al. Current Diabetes Reports
- Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
- (2010) Le Min et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Distinct Clinical Courses in Type 1 Diabetes Mellitus Induced by Peg-interferon-α Treatment for Chronic Hepatitis C
- (2010) Masanori Yamazaki et al. INTERNAL MEDICINE
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
- (2009) DIABETES CARE
- Interferon- initiates type 1 diabetes in nonobese diabetic mice
- (2008) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B
- (2008) Yuan-Yuan Lv et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started